Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib

Siraj M Ali, R Kathy Alpaugh, Jamie K Buell, Philip J Stephens, Jian Qin Michael Yu, Hong Wu, Christine N Hiemstra, Vincent A Miller, Doron Lipson, Gary A Palmer, Jeffrey S Ross, Massimo Cristofanilli

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib'. Together they form a unique fingerprint.

Medicine and Dentistry